Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS National Generic Pharmaceuticals - Clozapine
Offer reference number: CM/PHG/21/5634
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.
Potential periods of call-offs under the framework agreement:
1st August 2021 to 31st July 2023
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Britannia Pharmaceuticals | 01557088 | ~£17,670,738 estimated from lot values | - |
| Leyden Delta B.V. | - | ~£17,670,738 estimated from lot values | - |
| Mylan | 05460854 | ~£17,670,738 estimated from lot values | - |
Government spending data: These suppliers have received £113,000 in 1 payments (over £25k) from Department of Health and Social Care (2014-10-01 to 2014-10-01).